OYO Rolls Out #FightCovidwithOYO Campaign With Donate A Night and Book A Night for Self-Isolation to Help Flatten the Curve
European Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ NSCLC
Merck Foundation Together With African First Ladies Announce ‘Stay at Home’ Media Recognition Awards
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Visa Foundation Commits $210 Million to Support Small and Micro Businesses and Immediate COVID-19 Emergency Relief
LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors